ArriVent BioPharma, Inc. Financial Overview
ArriVent BioPharma, Inc.'s market cap is currently $954.01M. The company's EPS TTM is $-0.83; its P/E ratio is -5.25; ArriVent BioPharma, Inc. is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.88. See an overview of income statement, balance sheet, and cash flow financials.
